Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Critical Care (London, England)|May 2, 2015
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsisPengfei Li, Youming Guo, Grant Bledsoe, et al.
Human Gene Therapy|February 4, 2006
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesisChun-Fang Xia, Hang Yin, Yu-Yu Yao, et al.
American Journal of Physiology. Renal Physiology|January 22, 2010
Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradationYuying Liu, Grant Bledsoe, Makato Hagiwara, et al.
Molecular and Cellular Biology|August 5, 2003
Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesisKoh Kawasaki, Robert S Smith, Chung-Ming Hsieh, et al.
Biological Chemistry|May 21, 2010
Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathwayLin Gao, Robert S Smith, Li-Mei Chen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2006
Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosisGrant Bledsoe, Sarah Crickman, Jenny Mao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 20, 2013
Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesisYuyu Yao, Zulong Sheng, YeFei Li, et al.
The Journal of Gene Medicine|July 9, 2004
Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive ratsLi-Guo Chen, Zheng-Rong Wang, Chao-Min Wan, et al.
Cardiovascular Research|December 2, 2006
Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activationHuey-Jiun Li, Hang Yin, Yu-Yu Yao, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2003
Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive ratsChunxia Zhao, Peihua Wang, Xiao Xiao, et al.
Pageof 11